Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralesional Injection of Steroids and/or Botulinum Toxin Type A in Hypertrophic Scars and Keloids for Pain Improvement

NCT03982862 is registered in ClinicalTrials.gov with Kaohsiung Medical University as lead sponsor.

NCT NCT03982862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03982862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralesional Injection of Steroids and/or Botulinum Toxin Type A in Hypertrophic Scars and Keloids for Pain Improvement
Lead sponsor
Kaohsiung Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
July 30, 2018
Completion date
June 30, 2019
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic scar, scar keloid